Patent Assignment
Reel/Frame 055354/0063
Security Interest
Recorded: 2021-02-22
Pages: 9
Assignor
COVIS PHARMA GMBH
Executed: 2021-02-10
Assignee
CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
77 W. WACKER DRIVE, 10TH FLOOR, CHICAGO, ILLINOIS, 60661
Covered Properties
(37)
Heat Stable Colloidal Iron Oxides Coated with Reduced Carbohydrates and Carbohydrate Derivatives
Patent:
6,599,498 →
Application:
09/521,264 →
Combination of riluzole and of gabapentin and its use as a medicament
Patent:
6,350,768 →
Application:
09/718,543 →
Riluzole and Alpha-Tocopherol Combination
Composition with Sustained Release of Levodopa and Carbidopa
Ciclesonide Contained Pharmaceutical Composition for Application to Mucosa
Patent:
6,767,901 →
Application:
10/110,629 →
Ciclesonide Containing Aqueous Pharmaceutical Composition
Patent:
8,383,611 →
Application:
10/110,632 →
Process for the Production of 16,17-[{Cyclohexylmethylen)Bis(Oxy)]-11,21-Dihydroxy-Pregna-1,4-Dien-3,20-Dion or Its 21-Isobutyrat by Transketalisation
Ciclesonide-Containing Sterile Aqueous Suspension
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Combination Medicament
Process for preparing crystalline ciclesonide with defined particle size
Formoterol and Ciclesonide Combination
Use of Ciclesonide for the Treatment of Respiratory Diseases
Compliance monitor and method
Stabilized Pharmaceutical Product
Stable Pharmaceutical Products
Ciclesonide containing sterile aqueous suspension
Ciclesonide-Containing Sterile Aqueous Suspension
Stabilized Pharmaceutical Product
Stable Pharmaceutical Products
Combination Medicament
Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis
Stabilized Pharmaceutical Product
Stabilized Pharmaceutical Product
Anticoagulant Reversal Agents
Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation
Labeled Compounds and Methods of Imaging, Diagnosing Cartilage Disorders and Diseases, and Monitoring Cartilage Health Using Labeled and Unlabeled Compounds
Stable Glucagon Formulations
Aqueous Suspensions of Ciclesonide for Nebulisation
Anticoagulant Reversal Agents
Methods of Reducing Risk of Preterm Birth
Patent:
9,844,558 →
Application:
15/373,262 →
Methods of Reducing Risk of Preterm Birth
Patent:
10,471,075 →
Application:
15/709,941 →
Anticoagulant Reversal Agents
Application:
15/726,497 →
Publication:
US 2018/0207152
Crystalline and Amorphous Forms of 17-Alpha-Hydroxyprogesterone Caproate
Use of Ciclesonide for the Treatment of Respiratory Diseases
Application:
16/440,557 →
Publication:
US 2019/0290661
Methods of Reducing Risk of Preterm Birth
Metered Dose Inhaler
Patent:
582,544 →
Application:
29/283,277 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019781/0225 →
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019783/0625 →
Change of Name
Mar 26, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030091/0737 →
Security Agreement
Sep 17, 2013
From: DRUGTECH CORPORATION
To: LAW DEBENTURE TRUST COMPANY OF NEW YORK, AS AGENT
Reel/Frame 031226/0883 →
Change of Name
Jul 9, 2014
From: DRUGTECH CORPORATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 033282/0265 →
Release of Security Interests in Intellectual Property
Oct 20, 2014
From: LAW DEBENTURE TRUST COMPANY OF NEW YORK
To: K-V PHARMACEUTICAL COMPANY
Reel/Frame 034018/0040 →
Security Interest
Nov 12, 2014
From: AMAG PHARMACEUTICALS, INC.
To: JEFFERIES FINANCE LLC
Reel/Frame 034156/0214 →
Security Interest
Nov 12, 2014
From: LUMARA HEALTH IP LTD
To: JEFFERIES FINANCE LLC
Reel/Frame 034156/0243 →
Release of Patent Security Interest
Apr 21, 2015
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: COVIS PHARMA S.A.R.L.; COVIS PHARMA HOLDINGS S.A.R. L.
Reel/Frame 035475/0336 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0478 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0224 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0179 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
Security Interest
Sep 25, 2015
From: LUMARA HEALTH IP LTD.
To: JEFFERIES FINANCE LLC
Reel/Frame 036653/0138 →
Security Interest
Sep 25, 2015
From: AMAG PHARMACEUTICALS, INC.
To: JEFFERIES FINANCE LLC
Reel/Frame 036653/0065 →
Release of Security Interest
Oct 1, 2015
From: WILLMINGTON TRUST, NATIONAL ASSOCIATION
To: LUMARA HEALTH IP LTD
Reel/Frame 036704/0822 →
Release of Security Interest
Oct 9, 2015
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 036763/0475 →
Merger
Feb 15, 2016
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 037820/0324 →
Merger
Feb 15, 2016
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 037820/0360 →
Change of Name
Feb 15, 2016
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 038020/0258 →
Assignment of Assignor's Interest
Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
Release of Security Interest
May 15, 2017
From: JEFFERIES FINANCE LLC
To: LUMARA HEALTH IP LTD.
Reel/Frame 042461/0626 →
Release of Security Interest
May 15, 2017
From: JEFFERIES FINANCE LLC
To: AMAG PHARMACEUTICALS, INC.
Reel/Frame 042459/0824 →